
At least five people have been killed in a bomb explosion in a packed mosque in Nigeria's north-eastern Borno state, a police spokesman has said.
Nahum Daso told local media another 35 people were injured in the blast in the Gamboru market of Maiduguri, the state capital, during evening prayers.
Unverified footage on social media appears to show the aftermath of the explosion, with people stood in a market area with dust particles in the air.
No group has admitted carrying out the attack, but militants have previously targeted mosques and crowded places in the area with suicide attacks and improvised explosive devices (IED).
Maiduguri has been central to an insurgency by the militant Islamist group Boko Haram and its offshoot Islamic State West Africa Province.
Military operations by Boko Haram to create an Islamic caliphate in Borno state began in 2009.
Security measures against the group have failed to prevent sporadic attacks against civilians in north-east Nigeria.
LATEST POSTS
- 1
Army commander convicted of Guinea stadium massacre dies in prison - 2
My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs - 3
Glamour Shots once ruled the mall. I went to one of the last ones standing. - 4
The Way to Monetary Health: Individual budget Change - 5
How Seniors Can Use Refunds and Motivators to Purchase a Hyundai Ioniq EV
This cafe takes orders in sign language. It's cherished by the Deaf community
Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
Native artists in Texas and Mexico shared their vision of the universe for 4,000 years, ancient murals suggest
Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
Like many holiday traditions, lighting candles and fireplaces is best done in moderation
German official report: Teen social media ban faces legal hurdles
8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
Eleven Creations And Developments That Steered History
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas













